İsmet Taşdelen

673 total citations
28 papers, 408 citations indexed

About

İsmet Taşdelen is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, İsmet Taşdelen has authored 28 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in İsmet Taşdelen's work include Breast Cancer Treatment Studies (8 papers), BRCA gene mutations in cancer (5 papers) and Breast Lesions and Carcinomas (5 papers). İsmet Taşdelen is often cited by papers focused on Breast Cancer Treatment Studies (8 papers), BRCA gene mutations in cancer (5 papers) and Breast Lesions and Carcinomas (5 papers). İsmet Taşdelen collaborates with scholars based in Türkiye. İsmet Taşdelen's co-authors include Ünal Egelí, Berrin Tunca, Uğur Topal, Gülşah Çeçener, Türkkan Evrensel, Şahsine Tolunay, Şaduman Balaban Adım, Gülçin Tezcan, Elif Ertürk and Billur Şamli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Molecular and Cellular Biochemistry.

In The Last Decade

İsmet Taşdelen

27 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
İsmet Taşdelen Türkiye	14	186	135	134	129	92	28	408
Piotr Skotnicki Poland	12	98 0.5×	135 1.0×	51 0.4×	108 0.8×	80 0.9×	31	392
C P Hinton United Kingdom	11	163 0.9×	158 1.2×	58 0.4×	116 0.9×	145 1.6×	20	430
Nhu Ngo United States	7	101 0.5×	105 0.8×	70 0.5×	107 0.8×	43 0.5×	22	289
Cosmin Moldovan Romania	9	198 1.1×	173 1.3×	44 0.3×	91 0.7×	46 0.5×	38	377
Kandice K. Ludwig United States	10	197 1.1×	144 1.1×	53 0.4×	176 1.4×	147 1.6×	36	465
Mitsuo Terada Japan	11	140 0.8×	239 1.8×	112 0.8×	70 0.5×	46 0.5×	36	402
LFAG Massuger Netherlands	6	126 0.7×	113 0.8×	31 0.2×	151 1.2×	78 0.8×	9	457
Massimo Scheibel Italy	9	142 0.8×	182 1.3×	46 0.3×	87 0.7×	24 0.3×	14	290
Jane Lynch United States	11	170 0.9×	290 2.1×	112 0.8×	386 3.0×	59 0.6×	12	593
Nagayoshi Ohta Japan	15	273 1.5×	218 1.6×	60 0.4×	164 1.3×	284 3.1×	35	584

Countries citing papers authored by İsmet Taşdelen

Since Specialization

Citations

This map shows the geographic impact of İsmet Taşdelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İsmet Taşdelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İsmet Taşdelen more than expected).

Fields of papers citing papers by İsmet Taşdelen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İsmet Taşdelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İsmet Taşdelen. The network helps show where İsmet Taşdelen may publish in the future.

Co-authorship network of co-authors of İsmet Taşdelen

This figure shows the co-authorship network connecting the top 25 collaborators of İsmet Taşdelen. A scholar is included among the top collaborators of İsmet Taşdelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İsmet Taşdelen. İsmet Taşdelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taşdelen, İsmet, et al.. (2019). Ultrasound-guided percutaneous drainage as an alternative to surgery in treating breast abscesses. The European Research Journal. 5(5). 809–815.

Taşdelen, İsmet, et al.. (2016). Gestational Gigantomastia. SHILAP Revista de lepidopterología. 12(2). 86–87. 15 indexed citations

Ak, Seçil, Gamze Güney Eskiler, Elif Ertürk, et al.. (2016). Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.. PubMed. 17(9). 4241–4246. 23 indexed citations

Çeçener, Gülşah, et al.. (2016). Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey. Molecular Biology Reports. 43(11). 1273–1284. 6 indexed citations

Ertürk, Elif, Gülşah Çeçener, Gülçin Tezcan, et al.. (2014). BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer. Gene. 556(2). 163–169. 18 indexed citations

Çeçener, Gülşah, Ünal Egelí, Berrin Tunca, et al.. (2014). BRCA1/2Germline Mutations and Their Clinical Importance in Turkish Breast Cancer Patients. Cancer Investigation. 32(8). 375–387. 19 indexed citations

Ertürk, Elif, Gülşah Çeçener, Ünal Egelí, et al.. (2014). Evaluation of Genetic Variations in miRNA-Binding Sites of BRCA1 and BRCA2 Genes as Risk Factors for the Development of Early-Onset and/or Familial Breast Cancer. Asian Pacific Journal of Cancer Prevention. 15(19). 8319–8324. 12 indexed citations

Özmen, Vahit, Engin Ok, Nuh Zafer Cantürk, et al.. (2014). Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies. European Journal of Public Health. 25(1). 9–14. 35 indexed citations

Taşdelen, İsmet, et al.. (2013). A comparison of Ki 67 proliferative index in primary tumor and axillary metastatic lymph nodes with length of survival in patients with breast cancer. Bratislavské lekárske listy/Bratislava medical journal. 114(11). 645–649. 7 indexed citations

10.

Tunca, Berrin, Ünal Egelí, Gülşah Çeçener, et al.. (2012). CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.. PubMed. 98(2). 243–51. 11 indexed citations

11.

Tunca, Berrin, Ünal Egelí, Gülşah Çeçener, et al.. (2012). CK19, CK20, EGFR and HER2 Status of Circulating Tumor Cells in Patients with Breast Cancer. Tumori Journal. 98(2). 243–251. 15 indexed citations

12.

Tolunay, Şahsine, et al.. (2011). Histopathologic Characteristics of Sentinel Lymph Node Biopsy in Breast Carcinoma: Uludağ University Faculty of Medicine Experience. Turkiye Klinikleri Journal of Medical Sciences. 31(6). 1324–1329. 2 indexed citations

13.

Ursavaş, Ahmet, et al.. (2007). Breast and osteoarticular tuberculosis in a male patient. Diagnostic Microbiology and Infectious Disease. 58(4). 477–479. 4 indexed citations

14.

Egelí, Ünal, Gülşah Çeçener, Berrin Tunca, & İsmet Taşdelen. (2006). Novel GermlineBRCA1andBRCA2Mutations in Turkish Women with Breast and/or Ovarian Cancer and Their Relatives. Cancer Investigation. 24(5). 484–491. 16 indexed citations

15.

Demiray, Mutlu, Ender Kurt, Türkkan Evrensel, et al.. (2005). Phase II Study of Gemcitabine Plus Paclitaxel in Metastatic Breast Cancer Patients with Prior Anthracycline Exposure. Cancer Investigation. 23(5). 386–391. 8 indexed citations

16.

Topal, Uğur, et al.. (2005). Role of ultrasound-guided core needle biopsy of axillary lymph nodes in the initial staging of breast carcinoma. European Journal of Radiology. 56(3). 382–385. 52 indexed citations

17.

Çetintaş, Sibel, et al.. (2002). Factors influencing cosmetic results after breast conserving management (Turkish experience). The Breast. 11(1). 72–80. 15 indexed citations

18.

Şamli, Billur, et al.. (2000). Primary Neuroendocrine Small Cell Carcinomaof the Breast. Archives of Pathology & Laboratory Medicine. 124(2). 296–298. 49 indexed citations

19.

Çeçener, Gülşah, et al.. (1998). Common fragile site expression and genetic predisposition to breast cancer. Teratogenesis Carcinogenesis and Mutagenesis. 18(6). 279–291. 1 indexed citations

20.

Sarıhan, Haluk, et al.. (1997). Traumatic asphyxia in children.. PubMed. 38(1). 93–5. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact